Uveitis Intermediate

• CLINICAL_TRIALS trial_result · 2021-08-03
  Clinical Trial Update: Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer) [Phase 4]

  Phase 4 trial update on Acthar Gel for inflammation of the eye's uvea, with terminated status and posted results.

• CLINICAL_TRIALS trial_result · 2021-06-15
  Clinical Trial Update: Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis [Phase 3]

  Phase 3 trial evaluating suprachoroidal CLS-TA injection for non-infectious uveitis has completed; results posted in 2021.

• CLINICAL_TRIALS trial_result · 2021-05-07
  Clinical Trial Update: MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301

  Extension study update for patients with non-infectious uveitis who participated in CLS1001-301 (MAGNOLIA) has completed with results posted…

• CLINICAL_TRIALS trial_result · 2021-04-28
  Clinical Trial Update: Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis [Phase 3]

  Phase 3 trial update for suprachoroidal CLS-TA injections in macular edema due to non-infectious uveitis has completed with results posted.

• CLINICAL_TRIALS trial_result · 2012-06-22
  Clinical Trial Update: A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis [Phase 3]

  Phase 3 trial evaluating LX211 for non-infectious uveitis has completed. The study examined posterior, intermediate, and pan-uveitis.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.